Introduction to Candidiasis: An Opportunistic Fungal Infection
Candidiasis, also commonly referred to by its synonyms candidosis, moniliasis, or thrush, is an opportunistic fungal infection caused by species of the genus Candida. Candida is a type of yeast-like fungus, which is a eukaryotic organism and a natural commensal of the human body, commonly colonizing the oral cavity, gastrointestinal tract, vagina, and skin surfaces. In a healthy host, the endogenous bacterial microflora and a robust immune system maintain the Candida population in check, ensuring it remains harmless. The infection only becomes symptomatic or pathogenic when an imbalance occurs, creating favorable conditions for overgrowth and tissue invasion. While a single species, Candida albicans, is the most frequently isolated causative agent, accounting for over 65% of infections, four other species—C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei—are collectively responsible for more than 90% of all Candida-related infections globally.
Classification and Spectrum of Candidiasis
Candidiasis is broadly classified based on the site and depth of the infection into two main categories: superficial (or mucosal/cutaneous) and systemic (or invasive). Superficial infections are localized and typically affect the mucous membranes and skin, presenting a lower risk of mortality but often causing significant discomfort and morbidity. Systemic or invasive candidiasis, conversely, is a life-threatening condition where the fungus enters the bloodstream, a state known as candidemia, and subsequently spreads to deep-seated organs. The clinical spectrum of the disease is vast, ranging from the common, mild ‘thrush’ in infants and denture wearers to severe, multi-organ failure in intensive care unit (ICU) patients.
Manifestations of Superficial and Mucosal Candidiasis
The most common forms of candidiasis are those involving the mucous membranes and the skin. Oral candidiasis, or oral thrush, is characterized by the overgrowth of C. albicans on the oral mucosa, often appearing as white, soft, slightly elevated plaques on the tongue, palate, or buccal mucosa, which, in some types, are non-scrapable. These oral forms include pseudomembranous candidiasis (the classic thrush), erythematous candidiasis, and chronic hyperplastic candidiasis. Secondary or associated lesions also include angular cheilitis (cracking at the corners of the mouth), median rhomboid glossitis, and denture stomatitis, the latter occurring frequently in denture users.
Vulvovaginal candidiasis, commonly known as a vaginal yeast infection, is a frequent affliction for women, often causing burning, itching, and abnormal discharge. This condition is frequently triggered by factors that disrupt the vaginal microflora, such as the use of local or systemic antimicrobial therapy, hormonal changes associated with pregnancy, or the use of oral contraceptives. Cutaneous candidiasis involves the skin, typically forming red, raised patches in moist, warm intertriginous areas such as the underarms, groin, or under the breasts. A common manifestation is diaper rash in infants. Finally, nail candidiasis, or candidal paronychia, is an infection of the nail folds and cuticles, causing painful, erythematous swelling that, in severe cases, can lead to the separation of the nail plate from the nail bed.
Invasive Candidiasis and Emerging Drug Resistance
Invasive candidiasis is the most severe and life-threatening form, where Candida breaches mucosal or skin barriers to enter the bloodstream, resulting in candidemia. Once in the blood, the infection can disseminate to virtually any internal organ, leading to chronic disseminated candidiasis, endocarditis, meningitis, peritonitis, osteomyelitis, and endophthalmitis. Symptoms are often non-specific, presenting as fever and chills unresponsive to standard antibacterial treatments, making diagnosis challenging, which relies primarily on blood culture or the Beta-D-glucan assay. Invasive candidiasis is a leading cause of bloodstream infections in the United States and is associated with in-hospital mortality rates of approximately 30%.
A particular concern in modern clinical settings is the emergence of highly drug-resistant species, most notably Candida auris. Since its global emergence around 2009, C. auris has become a serious public health threat. It is concerning due to its multi-antimicrobial resistance, the high mortality rate associated with its invasive infections, and its capacity to spread easily between patients within healthcare environments, often colonizing and persisting on contaminated medical equipment and surfaces. Prevention measures like strict hand hygiene and antimicrobial stewardship are critical in controlling the spread of all invasive Candida species, particularly in high-risk patient populations.
Modes of Transmission and Risk Factors for Infection
Candidiasis is primarily an endogenous infection, meaning that the source of the infection is the patient’s own colonizing Candida flora. Most invasive and non-invasive infections arise when the integrity of the host’s skin and mucosal barriers is disrupted, allowing the fungus to invade. For systemic candidiasis, the most frequent route to the bloodstream is via the gastrointestinal tract mucosal barrier, although intravascular catheters and localized infections can also serve as entry points. Less common, but documented, routes of transmission include exogenous spread, such as contact with contaminated medical devices, healthcare workers’ hands in nosocomial settings, and, in cases of mucosal infection, mother-to-infant transmission during childbirth or breastfeeding, and rare sexual transmission.
A wide array of risk factors predispose individuals to candidiasis, all of which compromise host immunity or alter the microenvironment. These include underlying medical conditions such as diabetes mellitus, cancer, and HIV/AIDS; demographic factors like old age and infancy (where approximately 37% of newborns may be affected by thrush); physiological states like pregnancy; and medical interventions. Key iatrogenic risk factors involve the prolonged use of broad-spectrum antibiotics, which eliminate competing bacterial flora; the presence of central venous catheters, which provide a surface for biofilm formation and a direct route to the bloodstream; and chronic immunosuppression from chemotherapy or corticosteroids. Patients in critical care units, those undergoing abdominal surgery, and stem cell transplant recipients are also highly vulnerable to invasive disease.
Pathogenesis: Virulence Factors and Evasion Mechanisms
The pathogenesis of Candida species is mediated by a sophisticated repertoire of virulence factors that facilitate attachment, tissue invasion, and immune evasion. One of the most critical factors is the dimorphic nature of C. albicans, which can switch between a yeast form (for dissemination) and a hyphal (filamentous) form (for tissue penetration and invasion). The hyphal form is equipped with adhesins and invasins, such as the Als-3 proteins, which enable tight adherence to host cells and facilitate active penetration of the epithelial lining. Biofilm formation is another major virulence mechanism, particularly significant for infections associated with indwelling medical devices. Biofilms are complex communities of cells encased in an extracellular matrix, which provides a physical barrier that shields the fungi from host immune cells and dramatically increases resistance to antifungal agents, making biofilm-associated infections extremely difficult to treat and a major source of high morbidity and mortality in hospitalized patients.
Furthermore, in the setting of oral candidiasis, the overgrowth of the organism leads to the desquamation of epithelial cells and the accumulation of keratin, bacteria, and necrotic tissue, forming the characteristic pseudo-membrane that adheres closely to the mucosa. The ability of Candida to sense and respond to the local host environment, including changes in pH, nutrient availability, and immune status, allows it to transition from a harmless commensal to an invasive pathogen, illustrating the tight and opportunistic link between host factors and fungal virulence that defines candidiasis. Chronic mucocutaneous candidiasis represents a rare, persistent form often associated with defects in the host’s effective T-cell (specifically Th17) immune responses, further highlighting the centrality of immune status in controlling Candida infection.